X0508 4 2025-01-31 0000882095 GILEAD SCIENCES, INC. GILD 0001310204 Dickinson Andrew D GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Chief Financial Officer 1 Common Stock 2025-01-31 4 M 0 26170 57.92 A 156043 D Common Stock 2025-01-31 4 M 0 71850 72.34 A 227893 D Common Stock 2025-01-31 4 M 0 44160 65.38 A 273053 D Common Stock 2025-01-31 4 S 0 142180 97.22 D 129873 D Non-qualified Stock Option (Right to Buy) 57.92 2025-01-31 4 M 0 26170 0 D 2032-03-10 Common Stock 26170 104690 D Non-qualified Stock Option (Right to Buy) 72.34 2025-01-31 4 M 0 71850 0 D 2030-03-10 Common Stock 71850 0 D Non-qualified Stock Option (Right to Buy) 65.38 2025-01-31 4 M 0 44160 0 D 2029-11-10 Common Stock 44160 0 D The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. Sales prices reported for the transactions reported here range from $97.22 to $97.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson 2025-02-03